UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022896
Receipt number R000026342
Scientific Title An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system
Date of disclosure of the study information 2019/09/13
Last modified on 2019/03/13 17:01:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system

Acronym

An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system

Scientific Title

An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system

Scientific Title:Acronym

An exploratory study in developing a diagnostic method for rheumatic diseases using a photoacoustic imaging system

Region

Japan


Condition

Condition

Rheumatic diseases (rheumatoid arthritis, polymyalgia rheumatica, palindromic rheumatism, RS3PE syndrome, Sjogren's syndrome, psoriatic arthritis, seronegative spondyloarthropathy, systemic connective tissue disease).

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the imaging capability of synovitis (blood flow in the synovial hypertrophy) in joints, synovial bursa or tendon sheath using a photoacoustic imaging system for undifferentiated arthritis and rheumatic diseases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Contrast and volume of photoacoustic images corresponding to synovitis (blood flow in the synovial hyperplasia) in joints, synovial bursa or tendon sheath for undifferentiated arthritis and rheumatic diseases.

Key secondary outcomes

Incidence of adverse events by using the photoacoustic imaging system.
(Final monitoring is conducted within 90 days after intervention)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Photoacoustic Imaging
(Use of the device is for up to three days)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with undifferentiated arthritis and rheumatic disease (rheumatoid arthritis, polymyalgia rheumatica, palindromic rheumatism, RS3PE syndrome, Sjogren's syndrome, psoriatic arthritis, seronegative spondyloarthropathy, systemic connective tissue disease) those who were enrolled in KURAMA cohort study.
2. Patients who aged over 20 years and older at the time of informed consent.
3. Patients who have agreed to participate in this study from their own free will with document consents.

Key exclusion criteria

1. Pregnant and lactating patients
2. Patients who takes photosensitizer for photodynamic therapy
3. Patients with a cardiac pacemaker
4. Patients who are in poor general status
5. People who have any following complications in assessment body parts:
Open wounds, excoriations, acnes, surgical wounds.
Infected wounds.
Infections.
Neurological diseases and orthopedic disorders in which it is impossible to keep sitting or standing position.
6. People who have any following history of disorders:
Mental disorders.
Dementia.
7. Patients who are judged ineligible to enroll into this clinical study by the investigator or the sub-investigators due to communication difficulty, limitations in taking examination position and other reasons.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Shuichi
Middle name
Last name Matsuda

Organization

Graduate School of Medicine Kyoto University

Division name

Department of Orthopaedic Surgery

Zip code

606-8507

Address

54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan

TEL

075-751-3366

Email

seikei@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Kouichi
Middle name
Last name Murata

Organization

Graduate School of Medicine Kyoto University

Division name

Department of the Control for Rheumatic Diseases

Zip code

606-8507

Address

54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan

TEL

075-751-3366

Homepage URL


Email

morifuru@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Cabinet Office

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Canon Inc.

Name of secondary funder(s)

Canon Inc.


IRB Contact (For public release)

Organization

Kyoto University Hospital Ethics Committe

Address

Konoe-cho, Yoshida, Sakyo-ku, Kyoto, Japan

Tel

0757534680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 13 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

14

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 15 Day

Date of IRB

2016 Year 09 Month 08 Day

Anticipated trial start date

2016 Year 09 Month 08 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 27 Day

Last modified on

2019 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026342


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name